To the best of our knowledge, the present study is one of the largest controlled and randomized trials evaluating the efficacy of MBCT on cognitive functions and BDNF levels in individuals with BD, with two active treatment groups using structured protocols and a 6-month follow-up. This evidence concerns the gene BDNF and Behcet disease.